NeuroFlow
Philadelphia, US · Founded 2017 · Delaware corporation · 7 known investors
NeuroFlow builds behavioral health integration platforms that identify population behavioral health risk, engage individuals with acuity-specific resources, and give care teams data to make decisions. It serves healthcare organizations and health systems aiming to improve outcomes and lower total cost of care.
Founders & leadership
NeuroFlow was founded in 2017 by Christopher Molaro and Adam Pardes.
Investors · 7
Reported raises · per SEC filings
Form D private placements$45.4M disclosed across 5 rounds · 2017–2022
▶$25.5MraisedOct 2022 · 19 investors · Other TechnologyRule 506(b)
▶$25.5MraisedOct 2022 · 19 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark McAdooDirector
- Mark GoldsteinDirector
- Christopher MolaroExecutive Officer, Director
- Adam PardesExecutive Officer, Director
- Mark MillerDirector
- Alan Wayne TamarelliDirector
- Enrico PicazzoDirector
- Offering amount
- $35M
- Amount sold
- $25.5M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJan 2021 · 4 investors · Other TechnologyRule 506(b)
▶$11MraisedJan 2021 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark GoldsteinDirector
- Alan Wayne TamarelliDirector
- Adam PardesExecutive Officer, Director
- Christopher MolaroExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $11M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$6.9MraisedDec 2019 · 7 investors · Other TechnologyRule 506(b)
▶$6.9MraisedDec 2019 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher MolaroExecutive Officer, Director
- Mark GoldsteinDirector
- Alan Wayne TamarelliDirector
- Adam PardesExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $6.9M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.1MraisedAug 2018 · 16 investors · Other TechnologyRule 506(b)
▶$1.1MraisedAug 2018 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher MolaroExecutive Officer, Director
- Alan Wayne TamarelliDirector
- Adam PardesExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$906.3KraisedOct 2017 · 11 investors · Other TechnologyRule 506(b)
▶$906.3KraisedOct 2017 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alan Wayne TamarelliDirector
- Christopher MolaroExecutive Officer, Director
- Adam PardesExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $906.3K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCrisistextline170 shared keywordsCrisis Text Line is a nonprofit mental health organization providing free, confidential, 24/7 crisis intervention and support through a text-based platform staffed by trained volunteer Crisis Counselors. It helps people cope with issues such as stress, anxiety, loneliness, self-harm, and suicidal thoughts, and uses conversation data to inform mental health research and policy, with services in the U.S. and internationally.
Kff150 shared keywordsKFF conducts public opinion polling, research, and news analysis on health care policy issues in the United States, including topics such as Medicaid, Medicare, and the ACA. It serves the public, policymakers, and media with data and reporting on national health policy.
Companies competing with NeuroFlow for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.7M |
| National Science Foundation | Phase II | 2020 | $749.4K |
| U.S. Air ForceAir Force | Phase I | 2020 | $48.4K |
| U.S. Air ForceAir Force | Phase I | 2019 | $48.4K |
| National Science Foundation | Phase ISTTR | 2018 | $224.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NeuroFlow do?
- NeuroFlow builds behavioral health integration platforms that identify population behavioral health risk, engage individuals with acuity-specific resources, and give care teams data to make decisions. It serves healthcare organizations and health systems aiming to improve outcomes and lower total cost of care.
- Who founded NeuroFlow?
- NeuroFlow was founded by Christopher Molaro, Adam Pardes in 2017.
- Who are NeuroFlow's investors?
- NeuroFlow's investors include Corewell Health Ventures, Echo Health Ventures, HLM Venture Partners, MemorialCare Innovation Fund, Red & Blue Ventures, Ben Franklin Technology Partners, Chestnut Street Ventures.
- How much funding has NeuroFlow raised?
- NeuroFlow has disclosed $45.4M raised across 5 rounds.
- Where is NeuroFlow headquartered?
- NeuroFlow is headquartered in Philadelphia, US.